IL10 and lung disorder: This choice was made based on reports showing that exogenous delivery of IL‐10 ameliorates different lung diseases (Cypel et al, 2009; Shamskhou et al, 2019; Lindner et al, 2021) and because the lung is a challenging organ due to its reduced microbiome size (Huffnagle et al, 2017).